Log in to save to my catalogue

Antibacterial activities and action mode of anti-hyperlipidemic lomitapide against Staphylococcus au...

Antibacterial activities and action mode of anti-hyperlipidemic lomitapide against Staphylococcus au...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fa3392468b5f449d94fbf4031c4faf29

Antibacterial activities and action mode of anti-hyperlipidemic lomitapide against Staphylococcus aureus

About this item

Full title

Antibacterial activities and action mode of anti-hyperlipidemic lomitapide against Staphylococcus aureus

Publisher

England: BioMed Central Ltd

Journal title

BMC microbiology, 2022-04, Vol.22 (1), p.114-114, Article 114

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The increasing emergence of multidrug-resistant Gram-positive bacterial infections necessitates new antibacterial agents with novel mechanisms of action that can be used to treat these infections. Lomitapide has been approved by FDA for years in reducing levels of low-density lipoprotein (LDL) in cases of familial hypercholesterolemia, whereas the...

Alternative Titles

Full title

Antibacterial activities and action mode of anti-hyperlipidemic lomitapide against Staphylococcus aureus

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fa3392468b5f449d94fbf4031c4faf29

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fa3392468b5f449d94fbf4031c4faf29

Other Identifiers

ISSN

1471-2180

E-ISSN

1471-2180

DOI

10.1186/s12866-022-02535-9

How to access this item